Prochant: 'HME is no longer just HME'

CHARLOTTE, N.C. - Prochant is applying its “existing capabilities” in the HME market to the pharmacy and home infusion markets, and charging Jon Love, its new vice president of business development, with leading the way.

It's the first expansion into another market for the company, which got its start in HME in 1999, says Joey Graham.

“We're leveraging the existing capabilities that we have, with full-service billing and staff augmentation, and the revenue models and specialized solutions for each step of the process, including intake, and applying those to this new horizontal for us,” he said. “It's also a great opportunity to work with Jon.”

Love was previously director of sales for WellSky's home care division; and COO for Rock Pond Solutions, a software provider for home infusion, HME and specialty pharmacies. Prochant has also hired Tina Ratliff as pharmacy reimbursement manager.

The pharmacy and home infusion markets, like the HME market, face a complex reimbursement environment that makes specialized and expert billing key to their success, Love says.

“What we constantly hear from pharmacists, as well as HME providers that do home infusion, is that they want to get back to taking care of patients,” he said. “But every day they have to deal with reimbursement issues, whether it's CMS or Medi-Cal. Every drug contract is different; every payer is different. We provide the services that make their lives easier.”

Prochant is also seeing a blending of the HME, pharmacy and home infusion markets that makes a streamlined software partner more of a priority, Love says.

“HME is no longer just HME,” he said. “We're seeing companies with multiple business verticals happening, and that's the client we're really focused on - the enterprise-level client. We want to come in and help them grow their business again and stop retreating.”

After a number of years of active cross pollination among software providers for HME, pharmacy and home infusion, Prochant has numerous competitors in the pharmacy and home infusion markets.

“But no one else has brought the level of sophistication, the investment in technology and people, and the HITRUST certification,” Graham said, which the company expects to complete by the end of this year.